Contact this trialFirst, we need to learn more about you.
Regulatory T Cell Therapy
Regulatory T Cell Therapy for Kidney Transplants
Recruiting1 awardPhase 2
Chicago, Illinois
This trial is testing the safety and effectiveness of giving a type of immune cells called regulatory T cells (TRK-001) to prevent rejection of a transplanted kidney from a living donor. Patients
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service